Skip to main content
SpringerLink
Log in

The Amyloidoses

  • Chapter
Primer on the Rheumatic Diseases

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Sipe JD, Cohen AS. Review: history of the amyloid fibril. J Struct Biol 2000;130:88–98.

    Article  PubMed  CAS  Google Scholar 

  2. Majno G, Joris I. Extracellular pathology. In: Cells, tissues, and disease: principles of general pathology. Oxford: Oxford University Press; 2004:250–267.

    Google Scholar 

  3. Pepys MB. Amyloidosis. Annu Rev Med 2006;57:223–241.

    Article  PubMed  CAS  Google Scholar 

  4. Merlini G, Bellotti V. Mechanisms of disease: molecular mechanisms of amyloidosis. N Engl J Med 2003;349: 583–596.

    Article  PubMed  CAS  Google Scholar 

  5. Buxbaum J. The amyloidoses. In: Klippel JH, Dieppe PA, eds. Rheumatology. Mosby yearbook. 1998;8.27.1–8.27.10.

    Google Scholar 

  6. Kyle RA, Linos A, Beard CM, et al. Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood 1992;79: 1817–1822.

    PubMed  CAS  Google Scholar 

  7. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 1995;32:45–59.

    PubMed  CAS  Google Scholar 

  8. Skinner M, Anderson J, Simms R, et al. Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchi cine only. Am J Med 1996;100:290–298.

    Article  PubMed  CAS  Google Scholar 

  9. Kyle RA, Gertz MA, Greipp PR, et al. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med 1997;336:1202–1207.

    Article  PubMed  CAS  Google Scholar 

  10. Comenzo RL. Amyloidosis. Curr Treat Options Oncol 2006;7:225–236.

    Article  PubMed  Google Scholar 

  11. Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 2001;358:24–29.

    Article  PubMed  CAS  Google Scholar 

  12. Booth DR, Booth SE, Gillmore JD, Hawkins PN, Pepys MB. SAA1 alleles as risk factors in reactive systemic AA amyloidosis. Amyloid 1998;5:262–265.

    PubMed  CAS  Google Scholar 

  13. Benson MD. Amyloidosis. In: Koopman WJ, Moreland LW, eds. Arthritis and allied conditions: a textbook of rheumatology. Philadelphia: Lippincott Williams & Wilkins; 2005:1933–1960.

    Google Scholar 

  14. Kay J. β2-microglobulin amyloidosis. Int J Exp Clin Invest 1997;4:187–211.

    CAS  Google Scholar 

  15. Miyata T, Inagi R, Iida Y, et al. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1. J Clin Invest 1994;93:521–528.

    Article  PubMed  CAS  Google Scholar 

  16. Georgiades CS, Neyman EG, Barish MA, Fishman EK. Amyloidosis: review and CT manifestations. Radiographics 2004;24:405–416.

    Article  PubMed  Google Scholar 

  17. Hawkins PN, Lavender JP, Pepys MB. Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component. N Engl J Med 1990;323:508–513.

    Article  PubMed  CAS  Google Scholar 

  18. Shah KB, Inoue Y, Mehra MR. Amyloidosis and the heart: a comprehensive review. Arch Intern Med 2006;166:1805–1813.

    Article  PubMed  CAS  Google Scholar 

  19. Falk RH, Plehn JF, Deering T, et al. Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. Am J Cardiol 1987;59:418–422.

    Article  PubMed  CAS  Google Scholar 

  20. Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005;111:186–193.

    Article  PubMed  Google Scholar 

  21. Westermark P, Stenkvist B. A new method for the diagnosis of systemic amyloidosis. Arch Intern Med 1973;132: 522–523.

    Article  PubMed  CAS  Google Scholar 

  22. Hachulla E, Janin A, Flipo RM, et al. Labial salivary gland biopsy is a reliable test for the diagnosis of primary and secondary amyloidosis. A prospective clinical and immunohistologic study in 59 patients. Arthritis Rheum 1993;36:691–697.

    Article  PubMed  CAS  Google Scholar 

  23. Comenzo RL, Zhou P, Fleisher M, Clark B, Teruya-Feldstein J. Seeking confidence in the diagnosis of systemic AL (Ig light-chain) amyloidosis: patients can have both monoclonal gammopathies and hereditary amyloid proteins. Blood 2006;107:3489–3491.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Massachusetts General Hospital, Boston, MA, USA

    Pasha Sarraf MD, PhD (Fellow)

  2. Department of Medicine, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA, USA

    Pasha Sarraf MD, PhD (Fellow)

  3. Department of Medicine, Harvard Medical School, Boston, MA, USA

    Jonathan Kay MD (Associate Clinical Professor, Director of Clinical Trials, Rheumatology Unit)

Authors
  1. Pasha Sarraf MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jonathan Kay MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Arthritis Foundation, Atlanta, GA, USA

    John H. Klippel MD (President and CEO) & Patience H. White MD, MA (Chief Public Health Officer) (President and CEO) &  (Chief Public Health Officer)

  2. Massachusetts General Hospital, Deputy Editor for Rheumatology UpToDate, Boston, MA, USA

    John H. Stone MD, MPH (Associate Physician) (Associate Physician)

  3. Division of Rheumatology & Women’s Health, University of Kentucky, Lexington, KY, USA

    Leslie J. Crofford MD (Gloria W. Singletary Professor of Internal Medicine, Chief) (Gloria W. Singletary Professor of Internal Medicine, Chief)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media, LLC.

About this chapter

Cite this chapter

Sarraf, P., Kay, J. (2008). The Amyloidoses. In: Klippel, J.H., Stone, J.H., Crofford, L.J., White, P.H. (eds) Primer on the Rheumatic Diseases. Springer, New York, NY. https://doi.org/10.1007/978-0-387-68566-3_69

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-68566-3_69

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-35664-8

  • Online ISBN: 978-0-387-68566-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation